[Bronchial asthma: progress in diagnosis and treatments. Topics: IV. Subtype/particular type/comorbidities; 1. Asthma phenotypes]. 2013

Takahiko Horiguchi
Department of Respiratory Medicine II, Fujita Health University School of Medicine, Japan.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015897 Comorbidity The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.

Related Publications

Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takahiko Horiguchi
June 2013, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!